Trials / Completed
CompletedNCT06172777
A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 801 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study to evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD, it is a multi-centre clinical study. sponsor by Astrazeneca Investment(China) Co.,LTD.
Detailed description
800 patients, including suspected or confirmed asthma, suspected or confirmed COPD, will be enrolled in nationwide multiple study centres. Enrolling suspected and confirmed subject in an approximate1:1 rate in centre-level. About 100 subjects were enrolled at the leader site, while about 14 subjects were enrolled at other sites. To evaluate the consistency of oscillometry and spirometry test results in patients with confirmed or suspected asthma or COPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | suspected asthma | enrollment 200 asthma patients |
| DIAGNOSTIC_TEST | suspected COPD | enrollment 200 COPD patients |
| DIAGNOSTIC_TEST | confirmed asthma | enrollment 200 patients |
| DIAGNOSTIC_TEST | confirmed COPD | enrollment 200 patients |
Timeline
- Start date
- 2024-02-08
- Primary completion
- 2024-08-30
- Completion
- 2024-08-30
- First posted
- 2023-12-15
- Last updated
- 2025-07-24
Locations
41 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06172777. Inclusion in this directory is not an endorsement.